申请人:Otsuka Pharmaceutical Co., Ltd.
公开号:US05034395A1
公开(公告)日:1991-07-23
Dihydropyridine derivatives and salts thereof represented by the general formula, ##STR1## which possess excellent calcium antagonist effect, hypotensive effect, platelets aggregation inhibitory effect, phosphodiesterase inhibitory effect, calmodulin inhibitory effect and peroxidized lipid lowering effect, and thus dihydropyridine derivatives and salts thereof are useful as a coronary blood flow improving agent such as coronary vasodilator, hypotensive agent, prophylaxis and treating agents for thrombosis, phophodiesterase inhibitory agent, peroxidized lipid metabolism lowering agent, anti-inflammatory agent and others.
二氢吡啶衍生物及其盐,由一般式##STR1##表示,具有优异的钙拮抗剂作用、降压作用、血小板聚集抑制作用、磷酸二酯酶抑制作用、钙调蛋白抑制作用和过氧化脂质降低作用。因此,二氢吡啶衍生物及其盐可用作冠状动脉血流改善剂,如冠状动脉扩张剂、降压剂、预防和治疗血栓的药物、磷酸二酯酶抑制剂、过氧化脂质代谢降低剂、抗炎剂等。